466 related articles for article (PubMed ID: 18285561)
21. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
23. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache.
Moore KL; Noble SL
Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098
[TBL] [Abstract][Full Text] [Related]
24. Aspirin in the treatment of acute migraine attacks.
Diener HC; Lampl C; Reimnitz P; Voelker M
Expert Rev Neurother; 2006 Apr; 6(4):563-73. PubMed ID: 16623655
[TBL] [Abstract][Full Text] [Related]
25. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
Friedman BW; Esses D; Solorzano C; Dua N; Greenwald P; Radulescu R; Chang E; Hochberg M; Campbell C; Aghera A; Valentin T; Paternoster J; Bijur P; Lipton RB; Gallagher EJ
Ann Emerg Med; 2008 Oct; 52(4):399-406. PubMed ID: 18006188
[TBL] [Abstract][Full Text] [Related]
27. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs.
Schulman EA; Dermott KF
Headache; 2003; 43(7):729-33. PubMed ID: 12890127
[TBL] [Abstract][Full Text] [Related]
28. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
Cady RK; Banks J; Jones BA; Campbell J
Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
[TBL] [Abstract][Full Text] [Related]
29. A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
Gori S; Morelli N; Acuto G; Caiola F; Iudice A; Murri L
Minerva Med; 2006 Dec; 97(6):467-77. PubMed ID: 17213783
[TBL] [Abstract][Full Text] [Related]
30. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Krymchantowski AV; Filho PF; Bigal ME
Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
32. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.
Silberstein SD; Schoenen J; Göbel H; Diener HC; Elkind AH; Klapper JA; Howard RA
Cephalalgia; 2009 Nov; 29 Suppl 2():17-27. PubMed ID: 19723122
[TBL] [Abstract][Full Text] [Related]
33. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
[TBL] [Abstract][Full Text] [Related]
34. Dosing and administration of ergotamine tartrate and dihydroergotamine.
Mathew NT
Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
[TBL] [Abstract][Full Text] [Related]
35. [Triptans versus other migraine medicine--secondary publication].
Tfelt-Hansen P
Ugeskr Laeger; 2009 Apr; 171(18):1485-7. PubMed ID: 19425262
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks].
Stepień A; Kozubski W
Wiad Lek; 2004; 57(3-4):135-9. PubMed ID: 15307520
[TBL] [Abstract][Full Text] [Related]
38. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
[TBL] [Abstract][Full Text] [Related]
39. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of migraine].
Hoffmann J; Reuter U
Dtsch Med Wochenschr; 2007 Oct; 132(41):2153-8. PubMed ID: 17924297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
